Literature DB >> 6474003

Separation and characterization of toxic and nontoxic forms of lipid A.

K Takayama, N Qureshi, E Ribi, J L Cantrell.   

Abstract

Highly purified and well-characterized samples of precursors and derivatives of bacterial lipopolysaccharides (LPS) were used to study the relationship between the chemical structure of lipid A and its toxicity. These samples included lipids X and Y (monosaccharide precursors of lipid A) from Escherchia coli MN7; incomplete lipid A (a disaccharide precursor of lipid A) from Salmonella typhimurium i50; and monophosphoryl lipid A, TLC-3 (a derivative of LPS), from S. typhimurium G30/C21. In addition, a diphosphoryl lipid A, TLC-3, was prepared from LPS of S. typhimurium G30/C21 and characterized by positive fast atom bombardment mass spectrometry. The diphosphoryl lipid A, TLC-3 fraction, was determined to be very toxic by the chick embryo lethal-dose test (CELD50 = 0.0064 microgram). Lipids X and Y, incomplete lipid A, and monophosphoryl lipid A (TLC-3), were all nontoxic (CELD50 greater than 10 micrograms). These results suggest a multiple structural requirement for toxicity of lipid A. Toxic lipid A must contain all of the following components: a glucosamine disaccharide, a sugar-1-phosphate, and normal fatty acid(s).

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6474003     DOI: 10.1093/clinids/6.4.439

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  33 in total

1.  Structural heterogeneity and environmentally regulated remodeling of Francisella tularensis subspecies novicida lipid A characterized by tandem mass spectrometry.

Authors:  Scott A Shaffer; Megan D Harvey; David R Goodlett; Robert K Ernst
Journal:  J Am Soc Mass Spectrom       Date:  2007-03-28       Impact factor: 3.109

2.  Bacterial endotoxins: comparison of mitogenic, polyclonal, antibody-inducing and toxicity activities.

Authors:  J Sourek; M Svobodová; R Dvorák; J Müller; K Sůla; K Nouza
Journal:  Folia Microbiol (Praha)       Date:  1991       Impact factor: 2.099

3.  Somnogenic activities of synthetic lipid A.

Authors:  A B Cady; S Kotani; T Shiba; S Kusumoto; J M Krueger
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

4.  Monophosphoryl lipid A behaves as a T-cell-independent type 1 carrier for hapten-specific antibody responses in mice.

Authors:  K R Myers; P Beining; M Betts; H Snippe; J Inman; B Golding
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

5.  Characterization of Lipid A Variants by Energy-Resolved Mass Spectrometry: Impact of Acyl Chains.

Authors:  Christopher M Crittenden; Lucas D Akin; Lindsay J Morrison; M Stephen Trent; Jennifer S Brodbelt
Journal:  J Am Soc Mass Spectrom       Date:  2016-12-13       Impact factor: 3.109

6.  Shiga toxin-associated hemolytic uremic syndrome: combined cytotoxic effects of shiga toxin and lipopolysaccharide (endotoxin) on human vascular endothelial cells in vitro.

Authors:  C B Louise; T G Obrig
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

7.  Ability of gonococcal and meningococcal lipooligosaccharides to clot Limulus amebocyte lysate.

Authors:  R I Roth; R Yamasaki; R E Mandrell; J M Griffiss
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Trehalose dimycolate enhances resistance to infection in neutropenic animals.

Authors:  G S Madonna; G D Ledney; T B Elliott; I Brook; J T Ulrich; K R Myers; M L Patchen; R I Walker
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

9.  Immunobiological activities of synthetic lipid A analogs with low endotoxicity.

Authors:  S Kotani; H Takada; I Takahashi; T Ogawa; M Tsujimoto; H Shimauchi; T Ikeda; H Okamura; T Tamura; K Harada
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

10.  Effect of monophosphoryl lipid A on host resistance to bacterial infection.

Authors:  J J Chase; W Kubey; M H Dulek; C J Holmes; M G Salit; F C Pearson; E Ribi
Journal:  Infect Immun       Date:  1986-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.